Fulton Books author Karen Underwood, an educator of thirty years who has worked as a classroom teacher, district coordinator, assistant principal, and principal, has completed her most recent book, “I’m Behind You!”: a charming tale full of the stories of inspirational Black American women to encourage young readers that they can accomplish any dream they have.
“‘I’m Behind You!’ is a story of a young girl going to bed at night with her mother telling her bedtime stories,” writes Underwood. “Each story is about real Black American women who were groundbreakers throughout history. These women were successful in music, politics, poetry, and acting. The stories shared with her daughter were to encourage the child to dream about the future. The mother wants her child to know that whatever she decides to accomplish in this life, she is behind her and loves her!
“For children of color, there are many opportunities open to you. Knowing your history will help you to prepare for your future. As an educator, mother, and grandmother, I want not only my children but all children to follow their dreams. Be inspired to be successful, and through it all, know that ‘I am Behind You, and I Do Love You!’”
Published by Fulton Books, Karen Underwood’s book is a beautiful tribute to the women it discusses, detailing their incredible contributions to help make society a more just and equal place. “I’m Behind You!” is a perfect tool to help uplift young readers and show them that one’s dreams are always worth pursuing, no matter what others might try to say.
Readers who wish to experience this enlightening work can purchase “I’m Behind You!” at bookstores everywhere, or online at the Apple iTunes store, Amazon, Google Play, or Barnes and Noble.
Please direct all media inquiries to Author Support via email at firstname.lastname@example.org or via telephone at 877-210-0816.
Fulton Books Media Relations 800-676-7845 www.fultonbooks.com
National Commission for Protection of Child Rights (NCPCR), has developed and launched a portal namely GHAR – GO Home and Re-Unite (Portal for Restoration and Repatriation of Child). The GHAR portal has been developed to digitally monitor and track the restoration and repatriation of children according to the protocol. The following are the salient features of the portal :
Digital tracking and monitoring of children who are in the Juvenile Justice system and have to be repatriated to another Country/State/District.
Digital transfer of cases of children to the concerned Juvenile Justice Board/Child Welfare Committee of the State. It will help in speedy repatriation of children.
Where there is a requirement of a translator/interpreter/expert, request will be made to the concerned State Government.
Child Welfare Committees and District Child Protection Officers can ensure proper restoration and rehabilitation of children by digitally monitoring the progress of the case of the child.
A checklist format will be provided in the forms so that the children who are being hard to repatriate or children who are not getting their entitled compensation or other monetary benefits can be identified.
List of Government implemented schemes will be provided, so that at the time of restoration the Child Welfare Committees can link the child with the schemes to strengthen the family and ensure that child remains with his/her family.
The Ministry of Women and Child Development is administering the Juvenile Justice (Care and Protection of Children) Act, 2015 (JJ Act, 2015) (as amended in 2021) and Rules thereunder, for ensuring safety, security, dignity and well-being of children. The Act provides for protection of children in need of care and protection and those in conflict with law by catering to their basic needs through care, protection, development, treatment and social re-integration.
Under the JJ Act, 2015 (Sections 27-30), the Child Welfare Committees have been empowered to take decisions with regard to the children in need of care and protection for the best interest of the children. They are also mandated to monitor the functioning of the Child Care Institutions (CCIs). Similarly, under section 106 of JJ Act, 2015, every State Government has to constitute a District Child Protection Unit (DCPU) for every district to take up matters relating to children to ensure the implementation of JJ Act, 2015 and rules thereunder. To ensure effective coordination in the Child Safety, Protection and Development; District Magistrates have been made the head of DCPUs. DMs have been empowered to review the functioning of DCPUs and CWCs at regular intervals to ensure prompt decisions as per provisions of JJ Act and Rules are taken by these bodies, keeping in mind best interests of Children.
This information was given by the Union Minister for Women & Child Development, Smt. Smriti Zubin Irani in a written reply in the Lok Sabha today.
Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced today that it had passed the milestone of exporting five million vehicles from Thailand. The local production and sales company, Mitsubishi Motors (Thailand) Co., Ltd. (hereafter, MMTh), currently has three production plants and one engine plant in Laem Chabang, Chonburi Province. This makes it Mitsubishi Motors’ largest production base outside of Japan.
Mitsubishi Motors established a sales company in Thailand in 1961 and began production in 1964. In 1988, the company became the first automotive manufacturer to start exporting from Thailand. Currently, MMTh has grown to export vehicles to more than 120 countries around the world, and in 2021, approximately 90 percent of the 340,000 vehicles* produced in Thailand were for export.
“Thailand is one of our most important bases, and its importance will continue to increase in the future,” said Takao Kato, president and chief executive officer, Mitsubishi Motors. “Reaching an export volume of five million vehicles is a step to the continuous growth and expansion of production volume in Thailand. We will continue to focus on Thailand as the main region that drives our activities in ASEAN countries, which are the foundation of our business. At the same time, we will contribute to the development of the automobile industry in Thailand.”
*Includes knockdown units.
About Mitsubishi Motors
Mitsubishi Motors Corporation (TSE:7211) –a member of the Alliance with Renault and Nissan–, is a global automobile company based in Tokyo, Japan, which has about 30,000 employees and a global footprint with production facilities in Japan, Thailand, Indonesia, mainland China, the Philippines, Viet Nam and Russia. Mitsubishi Motors has a competitive edge in SUVs, pickup trucks and plug-in hybrid electric vehicles, and appeals to ambitious drivers willing to challenge convention and embrace innovation. Since the production of our first vehicle more than a century ago, Mitsubishi Motors has been a leader in electrification–launched the i-MiEV -the world’s first mass-produced electric vehicle in 2009, followed by the Outlander PHEV –the world’s first plug-in hybrid electric SUV in 2013. The company announced a three-year business plan in July 2020 to introduce more competitive and cutting-edge models, including the Eclipse Cross (PHEV model), the all-new Outlander and the all-new Triton/L200.
For more information on Mitsubishi Motors, please visit the company’s website at www.mitsubishi-motors.com/en/.
Recently, Zhongke Guosheng (Hangzhou) Technology Co., Ltd (hereinafter referred to as “GS Biotech”) officially announced the completion of its nearly CNY100 million pre-A round financing, led by Legend Capital. The proceeds will be mainly used for the capacity expansion of core pipeline products 5-hydroxymethylfurfural (HMF), 2,5-furandicarboxylic acid (FDCA) and 2,5-tetrahydrofuran dimethanol (THFDM), and the continuous development of downstream derivatives. Founded in 2021 with the vision of “Biomass Change Lives”, GS Biotech is a bio-based material and R&D company dedicated to building a bio-based material industry chain. The members of its founding team graduated from the Dalian Institute of Chemical Physics, Chinese Academy of Sciences, and have nearly 20 years of research foundation and industrialization experience in the fields of biomass catalytic conversion and furan-based material design and development. At present, the R&D team building has also been completed from biomass, derivatives to polymers, which ensures the cutting-edge of the company’s product development and the availability of end products.
According to Dr. John Zhang, CEO of GS Biotech, the company has taken the development model of promoting the “two-wheel drive” of the dual track as an important strategic direction. On the one hand, the company has completely solved the problems of HMF cost and raw material sources; its original HMF continuous production process, which completed the verification of multi-dimensional cost reduction measures, has greatly reduced the production cost and effectively improved the efficiency, and it is expected that the production cost of HMF will be controlled within RMB10,000 per ton in the future three years from the extraction of non-grain raw material sources to the iterative path of the production process and to the planning of expanding production capacity. Meanwhile, the company has also reserved more than 20 kinds of high-value-added monomers and is simultaneously promoting the verification of the application of each monomer in the terminal market. Moreover, GS Biotech established a joint venture, Xinshengtai Materials, with an AI-powered drug R&D unicorn company XtalPi Inc to focus on using AI technology to accelerate the reverse design of derivatives and improve the development efficiency of downstream derivatives to further accelerate its high-efficiency and accurate market development process.
On the other hand, the company has also made significant progress in the design, R&D and industrialization of degradable new materials. The new biodegradable plastic PEOX, another important pipeline of the company, has completed the 150L pilot scale experiment and obtained market terminal verification. The performance indicators of PEOX can be compared with PGA and the price of the terminal product will be approximately RMB10,000/ton after the large-scale production. With the special performance of the product and the support of policies, many leading enterprises in the industry are negotiating with the company to sign an underwriting agreement to apply PEOX in the field of disposable packagings such as agricultural mulch, plastic bags, straws, and lunch boxes.
Legend Capital said: “Under the background of China’s strategy in carbon peaking and carbon neutrality and the pursuit of sustainable energy development, petroleum-based chemical materials will gradually be replaced by bio-based materials, which are produced from sustainable resources. HMF is an important bio-based platform compound with great potential for downstream derivatives. GS Biotech has pioneered the HMF continuous production process globally and realized the large-scale and low-cost production of HMF. It has opened the entire industry chain from upstream core monomers to terminal applications and innovatively introduced AI and high-throughput machine synthesis technology into the development of downstream derivative products. The core team of GS Biotech graduated from the Dalian Institute of Chemical Physics of the Chinese Academy of Sciences. With nearly 20 years of research foundation and industrialization experience in the field of biomass catalytic conversion, GS Biotech has shown strong capabilities in continuous R&D, production management, and resource integration. Legend Capital has long focused on technology investments linked to carbon peaking and carbon neutrality, and we look forward to working with GS Biotech to promote technological change in the field of bio-based materials.”
As an interdisciplinary subject of information science, life science and material science, synthetic biology and bio-based materials have always been the direction that Legend Capital has paid close attention to in the field of carbon-neutral technology investment. Legend Capital’s investments in the carbon-neutral field focus on energy decarbonization, vehicle electrification/intelligence, synthetic biology, etc. Energy decarbonization includes photovoltaic, wind power, and smart grid; vehicle electrification/intelligence includes lithium battery vehicles, hydrogen fuel cell vehicles, battery recycling and others; in the field of synthetic biology and bio-based materials, Legend Capital has invested in many outstanding companies such as Giant Biogene (02367.HK), GS Biotech, Huili Biotech, and Tidetron Bioworks Technology.
About Legend Capital
Founded in 2001, Legend Capital is a leading VC&PE investor focusing on the early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, and Seoul, Korea.
It currently manages USD and RMB funds of over US$10 billion in commitments, and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies by solid investment coverage and systematic post-investment value-add. Over the years, Legend Capital has also become a widely recognized name in bridging key resources in China and overseas through cross-border activities, and a valuable partner to Chinese and overseas investors.
Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy. As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative.
For more information, please visit www.legendcapital.com.cn/index_en.aspx and follow us on LinkedIn @Legend Capital (https://www.linkedin.com/company/legend-capital).
Hitachi Rail’s planned acquisition of Thales’ Ground Transportation Systems (GTS) business was announced in August 2021. Since that time, Hitachi Rail and Thales have been making steady progress towards securing the regulatory approvals necessary for the transaction to proceed, including achieving merger clearances in 9 out of the 13 required jurisdictions. Hitachi Rail is currently in discussion with the European Commission’s Directorate-General for Competition (DG Competition) with a view to securing approval of the transaction in the EU.
On 9 December, the UK’s Competition and Markets Authority (CMA) announced its intention to open a “Phase II” review of the transaction. The parties are reviewing the decision, but as a result it is now likely that the closing of the transaction will occur in the second half of 2023, instead of early 2023.
Hitachi Rail and Thales strongly believe in the competitive benefits of the transaction, which will deliver value for customers in the rail signalling and mobility sectors in the UK, Europe and globally. Despite being disappointed by impact of the CMA’s decision on the timeline, Hitachi Rail remains committed to working with Thales and all regulatory bodies to ensure the successful close of the transaction as soon as possible.
Hitachi Rail is a fully integrated, global provider of rail solutions across rolling stock, signalling, service & maintenance, digital technology and turnkey solutions. With a presence in 38 countries across three continents and over 12,000 employees, our mission is to contribute to society through the continuous development of superior rail transport solutions. Drawing on the wider Hitachi Group’s market-leading technology and research-and-development capabilities, we strive for industry leading innovations and solutions that can deliver value for customers and sustainable railway systems that benefit wider society. For more information about Hitachi Rail, visit www.hitachirail.com